Differentially expressed genes of RCC from Saudi patients on comparing RCC with normal kidney tissue. Transcriptomics profiling revealed 1490 differentially expressed genes, 1034 up-regulated and 456 down-regulated, with fold change ≥ 2 and p-value < 0.05. (XLSX 209 kb
To identify Cyclin A1-expressing solid cancer entities, HG U133 Plus 2.0 microarray data sets (Affym...
Results of drug screening for pRCC and mRCC tumors. Summarized list of drugs used in the screening a...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...
Figure S1. A: Flow chart of selecting dysregulated lncRNAs from two public RCC Dataset (GSE46699 and...
Table S1. lncRNAs significantly associated with the overall survival. Table S2. Patient and tumor ch...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Table S3. BX649059 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 27 kb
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Table S4. Clinical characteristics of 116 ccRCC patients according to URRCC expression levels. (XLSX...
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Additional file 1: Figure S1. Panoramic pictures of differentially expressed genes (DEGs). A Volcano...
Figure S4. A: Bioinformatics analysis of potential FOXO3 binding site on URRCC promoter by online so...
To identify Cyclin A1-expressing solid cancer entities, HG U133 Plus 2.0 microarray data sets (Affym...
Results of drug screening for pRCC and mRCC tumors. Summarized list of drugs used in the screening a...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...
Figure S1. A: Flow chart of selecting dysregulated lncRNAs from two public RCC Dataset (GSE46699 and...
Table S1. lncRNAs significantly associated with the overall survival. Table S2. Patient and tumor ch...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Table S3. BX649059 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 27 kb
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Table S4. Clinical characteristics of 116 ccRCC patients according to URRCC expression levels. (XLSX...
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Additional file 1: Figure S1. Panoramic pictures of differentially expressed genes (DEGs). A Volcano...
Figure S4. A: Bioinformatics analysis of potential FOXO3 binding site on URRCC promoter by online so...
To identify Cyclin A1-expressing solid cancer entities, HG U133 Plus 2.0 microarray data sets (Affym...
Results of drug screening for pRCC and mRCC tumors. Summarized list of drugs used in the screening a...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...